DILIC
ALXN

Dai-ichi Life Insurance Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,256
Closed -$1.7M – 578
2021
Q2 		$1.7M Hold
9,256
– – 0.02% 372
2021
Q1 		$1.42M Hold
9,256
– – 0.02% 392
2020
Q4 		$1.45M Hold
9,256
– – 0.02% 364
2020
Q3 		$1.06M Hold
9,256
– – 0.02% 382
2020
Q2 		$1.04M Sell
9,256
-574
-6% -$60.9K 0.02% 371
2020
Q1 		$883K Sell
9,830
-10,000
-50% -$981K 0.03% 371
2019
Q4 		$2.15M Buy
19,830
+221
+1% +$23.6K 0.05% 321
2019
Q3 		$1.92M Sell
19,609
-19,476
-50% -$2.2M 0.05% 331
2019
Q2 		$5.12M Sell
39,085
-6,155
-14% -$793K 0.12% 180
2019
Q1 		$6.12M Buy
45,240
+25,631
+131% +$3.19M 0.15% 149
2018
Q4 		$1.91M Sell
19,609
-147
-0.7% -$17.4K 0.05% 310
2018
Q3 		$2.75M Hold
19,756
– – 0.06% 283
2018
Q2 		$2.45M Hold
19,756
– – 0.06% 295
2018
Q1 		$2.2M Sell
19,756
-231
-1% -$27.6K 0.05% 304
2017
Q4 		$2.39M Hold
19,987
– – 0.05% 290
2017
Q3 		$2.8M Hold
19,987
– – 0.06% 267
2017
Q2 		$2.43M Buy
19,987
+3,717
+23% +$433K 0.05% 277
2017
Q1 		$1.97M Sell
16,270
-16,965
-51% -$2.19M 0.05% 299
2016
Q4 		$4.07M Buy
+33,235
New +$4.07M 0.12% 198

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Dai-ichi Life Insurance Company's ALXN Position: Q3 2021 in Review

Dai-ichi Life Insurance Company sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 9,256 shares — an estimated $1.7M sold.

Dai-ichi Life Insurance Company first reported a position in ALXN in Q4 2016 and held it in 19 quarters. The position peaked at $6.12M in Q1 2019. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Dai-ichi Life Insurance Company reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 9,256 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.7M.
  • Dai-ichi Life Insurance Company first reported a position in Alexion Pharmaceuticals in Q4 2016 and held it in 19 quarters.
  • Dai-ichi Life Insurance Company's Alexion Pharmaceuticals position peaked at $6.12M in Q1 2019.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Dai-ichi Life Insurance Company's 13F filing for Q3 2021, filed 4 Nov 2021.